| MedWatch Safety Alerts
from the Food and Drug Administration (FDA) |
Updated : Thu, 17 Jul 2008 15:45:00 EDT
Changes to the Boxed Warning, Warnings, and Contraindications sections of the prescribing information to reflect conclusions of FDA reviews of information received following the addition of new contraindications and warnings in October 2007. Publ.Date : Thu, 17 Jul 2008 15:45:00 EDT
Possible malfunction of Electronic Medical Devices caused by Computed Tomography (CT) Scanning on patients with implanted and external electronic medical devices. Publ.Date : Wed, 16 Jul 2008 14:30:00 EDT
Recall of 2 lots of the product due to the presence of yeast which could affect patients who are immunocompromised. Publ.Date : Wed, 16 Jul 2008 14:30:00 EDT
Reports of microangiopathic hemolytic anemia in patients treated with this unapproved combination. Publ.Date : Mon, 14 Jul 2008 14:30:00 EDT
Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of the Prescribing Information, plus Patient Package Inserts and Medication Guides. Publ.Date : Thu, 10 Jul 2008 15:09:00 EDT
Complaints of damaged and broken vials of Herceptin 440 mg and BWFI diluent that may lead to a loss of sterility, which may cause infections in patients. Publ.Date : Thu, 10 Jul 2008 13:14:00 EDT
BOXED WARNING and Medication Guide to be added to prescribing information to strengthen existing warnings about the increased risk of developing tendinitis and tendon rupture in patients taking fluoroquinolones for systemic use. Publ.Date : Tue, 08 Jul 2008 11:41:00 EDT
Certain lots of both products were recalled because they contained an undeclared ingredient. Publ.Date : Wed, 02 Jul 2008 16:13:00 EDT
Reports of life-threatening complications associated with recombinant human Bone Morphogenetic Protein when used in the cervical spine. Publ.Date : Wed, 02 Jul 2008 13:08:00 EDT
Dear Healthcare Professional Letter sent by manufacturer regarding reports of Progressive Multifocal Leukoencephalopathy in patients treated with Myfortic. Publ.Date : Tue, 01 Jul 2008 16:09:00 EDT
|
|
Sitemap | Privacy Policy |